Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse

Description

The purpose of this study is to compare two types of surgery for the treatment of uterovaginal prolapse to determine which surgery works best from a patient's perspective and has the lowest number of short-term and long-term complications.

Conditions

Uterine Prolapse

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to compare two types of surgery for the treatment of uterovaginal prolapse to determine which surgery works best from a patient's perspective and has the lowest number of short-term and long-term complications.

Patient-Centered Outcomes of Sacrocolpopexy Versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse

Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse

Condition
Uterine Prolapse
Intervention / Treatment

-

Contacts and Locations

Jacksonville

Mayo Clinic, Jacksonville, Florida, United States, 32224

Durham

Duke University, Durham, North Carolina, United States, 27707

Cleveland

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States, 44106

Cleveland

Cleveland Clinic, Cleveland, Ohio, United States, 44195

Pittsburgh

University of Pittsburgh, UPMC Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States, 15213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Women ≥ 18 years of age and ≤ 80 years of age
  • 2. Have diagnosis of symptomatic uterovaginal prolapse
  • 3. Have elected to undergo surgical management of uterovaginal prolapse after consultation with their physician
  • 4. Are eligible for both minimally invasive supracervical hysterectomy with sacrocolpopexy (MI-SCH+SCP) and total vaginal hysterectomy with uterosacral ligament suspension (TVH+USLS)
  • 1. Patients who wish to undergo uterine sparing procedures
  • 2. Body mass index BMI) \> 50
  • 3. Previous hysterectomy or prior uterovaginal surgery
  • 4. Have a diagnosis of neurogenic bladder, Parkinson's disease, multiple sclerosis, spinal cord injury, or cerebrovascular accident
  • 5. Chronic indwelling urinary catheter
  • 6. Urinary diversion of any type
  • 7. Any condition or disorder that, in the opinion of the investigator, might prevent the subject from completing the study or interfere with the interpretation of the study results
  • 8. Unable to speak, read, understand English

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University Hospitals Cleveland Medical Center,

Adonis Hijaz, MD, PRINCIPAL_INVESTIGATOR, University Hospitals Cleveland Medical Center

Study Record Dates

2030-07-31